Younossi et al., 2013 - Google Patents
Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis CYounossi et al., 2013
View PDF- Document ID
- 612250613704411579
- Author
- Younossi Z
- Zheng L
- Stepanova M
- Venkatesan C
- Mir H
- Publication year
- Publication venue
- Alimentary pharmacology & therapeutics
External Links
Snippet
Background The impact of moderate alcohol consumption on long‐term outcomes of chronic hepatitis C (CH‐C) infected patients remains controversial. Aim To assess the impact of moderate alcohol consumption on long‐term outcomes of CH‐C patients using population …
- 208000005176 Hepatitis C 0 title abstract description 108
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Younossi et al. | Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C | |
Younossi et al. | Associations of chronic hepatitis C with metabolic and cardiac outcomes | |
Le et al. | Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States | |
Tyson et al. | Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients | |
Gunji et al. | Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population | |
Jin et al. | Exercise and diet modification in non‐obese non‐alcoholic fatty liver disease: analysis of biopsies of living liver donors | |
Hashimoto et al. | The modest alcohol consumption reduces the incidence of fatty liver in men: a population‐based large‐scale cohort study | |
Tsai et al. | Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan | |
Kagansky et al. | Non‐alcoholic fatty liver disease–a common and benign finding in octogenarian patients | |
Frazier et al. | Treatment of alcoholic liver disease | |
Trimble et al. | Mortality associated with alcohol‐related liver disease | |
Wang et al. | The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses | |
Schneider et al. | Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study | |
Teschke et al. | Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? | |
Tsochatzis et al. | Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non‐alcoholic steatohepatitis | |
Duseja et al. | High prevalence of non‐alcoholic fatty liver disease among healthy male blood donors of urban India | |
Pourshams et al. | Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors | |
Hsu et al. | Increasing insulin resistance is associated with increased severity and prevalence of gastro‐oesophageal reflux disease | |
Park et al. | Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels | |
Perazzo et al. | Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia | |
Yoo et al. | Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality | |
Pattullo et al. | A 24‐week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C | |
Malnick et al. | Fatty liver disease-alcoholic and non-alcoholic: similar but different | |
Sahlman et al. | Genetic and lifestyle risk factors for advanced liver disease among men and women | |
Sookoian et al. | How safe is moderate alcohol consumption in overweight and obese individuals? |